ALRPD.PA Rapid Nutrition (EURONEXT) 13.64% pre-market 12 Feb 2026: rising volume

The ALRPD.PA stock opened the pre-market session higher after a strong intraday move, trading at €11.50, up 13.64% on a volume spike to 48,792 shares. Rapid Nutrition (ALRPD.PA) is listed on EURONEXT and the move follows heavy relative volume versus the 19,419 average. Investors should note the gap from the 50-day average of €4.53 and the 200-day average of €5.22, which frames this rally against a recent recovery trend in Europe’s healthcare names.

ALRPD.PA stock: Price action and volume

ALRPD.PA stock rallied from a previous close of €10.12 to a pre-market print of €11.50, with a session high of €13.00 and a low of €9.18. The trading volume of 48,792 is 2.51x the average, indicating active buying interest. On EURONEXT this spike contrasts with broader healthcare moves, where the sector shows muted short-term performance.

ALRPD.PA stock: Fundamentals and valuation

Rapid Nutrition reports EPS -22.85 and a negative PE of -0.48, reflecting recent losses. Market cap stands at €5,176,781 with 474,934 shares outstanding. Key balance metrics include a current ratio 3.57 and debt-to-equity 0.05, which show low leverage but very thin revenue per share. Price averages are 50-day €4.53 and 200-day €5.22, leaving the company above its longer-term trend lines.

ALRPD.PA stock: Technical signals

Momentum indicators are mixed: RSI 64.22 and CCI 200.34 sit in bullish territory and suggest short-term overbought conditions. ADX at 27.10 signals a developing trend. The surge pushed price well above the 50-day moving average, a common breakout marker for small caps on EURONEXT.

ALRPD.PA stock: Meyka AI grade and analyst context

Meyka AI rates ALRPD.PA with a score out of 100 — 62.23/100 (Grade B) with a HOLD suggestion. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. Note third-party company ratings also flag risk; a dated external rating lists C- with a Strong Sell view, showing mixed market views.

ALRPD.PA stock: Forecasts and price targets

Meyka AI’s forecast model projects a monthly price of €7.20 and a quarterly €0.72 figure in its raw output, which implies downside from today’s €11.50. For scenario planning we outline a near-term conservative target of €6.00 and a bullish recovery target of €20.00, based on past volatility and the €28.60 52-week high. Forecasts are model-based and not guarantees.

ALRPD.PA stock: Catalysts and risks

Catalysts include product rollouts, regulatory news, or contract wins that affect revenue per share. Key risks are sustained negative EPS, low liquidity relative to larger peers, and stretched valuation metrics like P/S 12.20 and P/B ~96,250 in raw data, reflecting thin accounting bases. Watch upcoming earnings dates and volume patterns on EURONEXT for confirmation.

Final Thoughts

ALRPD.PA stock shows a notable pre-market gain on 12 Feb 2026, backed by a 13.64% move to €11.50 and a clear jump in trading volume to 48,792. The rally places price well above the 50-day and 200-day averages, signalling renewed momentum, but company fundamentals remain mixed. Rapid Nutrition reports EPS -22.85, a negative PE, and small market cap €5,176,781, which keep valuation risk high. Meyka AI’s forecast model projects a monthly target of €7.20, implying an approximate -37.39% downside from the current price; this highlights model caution versus the intraday optimism. For risk-managed traders we recommend watching volume confirmation on EURONEXT and monitoring the April earnings date. Short-term traders can use the €13.00 intra-day high as an immediate reference, while longer horizon investors should weigh the €6.00 conservative target against the €20.00 recovery scenario. All forecasts are model-based projections and not guarantees. For full company details see Rapid Nutrition’s site and Euronext listings; for real-time signals consult Meyka AI’s stock page for ALRPD.PA for live updates and analytics.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.